| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |